Published in Int J Health Serv on January 01, 2010
The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries. Cancer Causes Control (2012) 1.53
International trade law, plain packaging and tobacco industry political activity: the Trans-Pacific Partnership. Tob Control (2013) 1.39
Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet (2015) 1.20
Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials. Tob Control (2012) 1.08
Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature. Global Health (2014) 1.02
Tobacco control and the World Trade Organization: mapping member states' positions after the framework convention on tobacco control. Tob Control (2015) 0.88
Are transnational tobacco companies' market access strategies linked to economic development models? A case study of South Korea. Glob Public Health (2013) 0.87
'A major lobbying effort to change and unify the excise structure in six Central American countries': How British American Tobacco influenced tax and tariff rates in the Central American Common Market. Global Health (2011) 0.81
Rhetoric and the law, or the law of rhetoric: How countries oppose novel tobacco control measures at the World Trade Organization. Soc Sci Med (2016) 0.79
Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging. Rev Int Polit Econ (2017) 0.75
Term limits and the tobacco industry. Soc Sci Med (2013) 0.75
Tobacco industry globalization and global health governance: towards an interdisciplinary research agenda. Palgrave Commun (2016) 0.75
Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control. Global Health (2017) 0.75
Looking inside the tobacco industry: revealing insights from the Guildford Depository. Addiction (2004) 3.86
Unlocking the corporate documents of British American Tobacco: an invaluable global resource needs radically improved access. Lancet (2004) 3.76
Smoke free hospitals. BMJ (2003) 3.05
The International Monetary Fund and tobacco: a product like any other? Int J Health Serv (2009) 2.77
Short-term impact of the smokefree legislation in England on emergency hospital admissions for asthma among adults: a population-based study. Thorax (2013) 2.17
Trends in and predictors of second-hand smoke exposure indexed by cotinine in children in England from 1996 to 2006. Addiction (2010) 2.09
Is the increasing policy use of Impact Assessment in Europe likely to undermine efforts to achieve healthy public policy? J Epidemiol Community Health (2010) 1.97
Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ (2010) 1.95
Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents. PLoS Med (2011) 1.82
Uneasy money: the Instituto Carlos Slim de la Salud, tobacco philanthropy and conflict of interest in global health. Tob Control (2010) 1.55
Determinants of smoking in eight countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Addiction (2004) 1.51
"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China. PLoS Med (2008) 1.51
Trends in the prevalence of smoking in Russia during the transition to a market economy. Tob Control (2007) 1.49
Ten years of the Global Alliance for Vaccines and Immunisation. BMJ (2010) 1.48
"Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents. PLoS Med (2010) 1.47
England's legislation on smoking in indoor public places and work-places: impact on the most exposed children. Addiction (2012) 1.45
Trade and health: an agenda for action. Lancet (2009) 1.41
Impact of smoke-free legislation on children's exposure to secondhand smoke: cotinine data from the Health Survey for England. Tob Control (2011) 1.39
Managing the pursuit of health and wealth: the key challenges. Lancet (2009) 1.34
TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines? Global Health (2007) 1.32
Status of implementation of Framework Convention on Tobacco Control (FCTC) in Ghana: a qualitative study. BMC Public Health (2010) 1.29
UK: price-based promotions target poor. Tob Control (2010) 1.25
Corporate Power and Social Policy: The Political Economy of the Transnational Tobacco Companies. Glob Soc Policy (2009) 1.23
Did smokefree legislation in England reduce exposure to secondhand smoke among nonsmoking adults? Cotinine analysis from the Health Survey for England. Environ Health Perspect (2011) 1.21
Framing global health: the governance challenge. Glob Public Health (2012) 1.21
Changes in smoking prevalence in 8 countries of the former Soviet Union between 2001 and 2010. Am J Public Health (2012) 1.15
Global health and foreign policy. Epidemiol Rev (2010) 1.11
Price and tax measures and illicit trade in the framework convention on tobacco control: what we know and what research is required. Nicotine Tob Res (2012) 1.05
Framing and global health governance: key findings. Glob Public Health (2012) 1.05
The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR. J Bus Ethics (2013) 1.04
Continuing influence of tobacco industry in Germany. Lancet (2002) 1.02
Type A behavior pattern and coronary heart disease: Philip Morris's "crown jewel". Am J Public Health (2012) 1.01
Tobacco industry manipulation of tobacco excise and tobacco advertising policies in the Czech Republic: an analysis of tobacco industry documents. PLoS Med (2012) 1.01
A race to the death: British American Tobacco and the Chinese Grand Prix. Lancet (2004) 0.99
Characterizing tobacco control mass media campaigns in England. Addiction (2013) 0.99
The national security implications of HIV/AIDS. PLoS Med (2006) 0.97
A review of the impacts of tobacco industry privatisation: Implications for policy. Glob Public Health (2011) 0.96
Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control. PLoS Med (2012) 0.95
Support for smoke-free policy, and awareness of tobacco health effects and use of smoking cessation therapy in a developing country. BMC Public Health (2011) 0.94
The "father of stress" meets "big tobacco": Hans Selye and the tobacco industry. Am J Public Health (2010) 0.94
Pricing Policies And Control of Tobacco in Europe (PPACTE) project: cross-national comparison of smoking prevalence in 18 European countries. Eur J Cancer Prev (2014) 0.91
Assessing the knowledge of the potential harm to others caused by second-hand smoke and its impact on protective behaviours at home. J Public Health (Oxf) (2011) 0.89
An evaluation of the International Monetary Fund's claims about public health. Int J Health Serv (2010) 0.89
Are transnational tobacco companies' market access strategies linked to economic development models? A case study of South Korea. Glob Public Health (2013) 0.87
Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation. Tob Control (2012) 0.86
The impact of televised tobacco control advertising content on campaign recall: evidence from the International Tobacco Control (ITC) United Kingdom Survey. BMC Public Health (2014) 0.85
Tobacco policies in Nazi Germany: not as simple as it seems. Public Health (2008) 0.85
Civil Society Organizations and the Functions of Global Health Governance: What Role within Intergovernmental Organizations? Glob Health Gov (2010) 0.84
Prevalence and psychosocial determinants of nicotine dependence in nine countries of the former Soviet Union. Nicotine Tob Res (2012) 0.84
Corporate social responsibility: serious cause for concern. Tob Control (2006) 0.83
Why we need to ban smoking in public places now. J Public Health (Oxf) (2004) 0.82
'A major lobbying effort to change and unify the excise structure in six Central American countries': How British American Tobacco influenced tax and tariff rates in the Central American Common Market. Global Health (2011) 0.81
Swedish snus for tobacco harm reduction. Lancet (2007) 0.81
Global Fund needs to address conflict of interest. Bull World Health Organ (2012) 0.81
The social determinants of adolescent smoking in Russia in 2004. Int J Public Health (2010) 0.80
Commentary: Smokeless tobacco: seeing the whole picture. Int J Epidemiol (2007) 0.80
Cigarette pack labelling in 12 countries at different levels of economic development. J Public Health Policy (2011) 0.79
Global health and national security: the need for critical engagement. Med Confl Surviv (2006) 0.79
"Fighting a hurricane": tobacco industry efforts to counter the perceived threat of Islam. Am J Public Health (2015) 0.76
To 'enable our legal product to compete effectively with the transit market': British American Tobacco's strategies in Thailand following the 1990 GATT dispute. Glob Public Health (2015) 0.76
The limits of global health diplomacy: Taiwan's observer status at the world health assembly. Global Health (2014) 0.76
Asthma admissions, smoking bans and administrative databases: author's response. Thorax (2013) 0.76
Is the UN broken, and can we fix it? BMJ (2005) 0.75
Globalisation and health. Informed and open debate on globalisation and health is needed. BMJ (2002) 0.75
Smoke free hospitals: withdrawal from cigarettes should not be confused with withdrawal from nicotine. BMJ (2003) 0.75
Public health advances. Concerns about tobacco control. BMJ (2010) 0.75
Germany: Tobacco industry still dictates policy. Tob Control (2007) 0.75
Tobacco companies start price war in Poland to offset tax rises. BMJ (2003) 0.75
Canada: Twisting the legacy name. Tob Control (2014) 0.75
Public health research funding: independence is important. Lancet (2010) 0.75
Reed Elsevier and the arms trade revisited. Lancet (2007) 0.75